ArticleScientific reports2026
Blood glucose trajectory phenotypes are associated with in-hospital mortality in a multicenter ICU stroke cohort.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Non-traumatic stroke (NTS) is associated with high mortality, and dynamic glucose patterns may provide prognostic information beyond static glucose measurements. This study aimed to identify glucose trajectory phenotypes in ICU patients with NTS and evaluate their association with in-hospital mortality. This multicenter retrospective cohort study included ICU patients with NTS from MIMIC-IV, eICU, and NSICU. Glucose trajectories during the first 168 h after ICU admission were identified using latent class growth modeling. Associations with in-hospital mortality were assessed using Cox regression, Kaplan-Meier analysis, competing-risk analysis, and subgroup analyses. Incremental predictive value was evaluated using AUC, integrated discrimination improvement (IDI), net reclassification improvement (NRI), and median improvement in predicted risk. Among 11,177 patients, four glucose trajectory phenotypes were identified: normoglycemia (NG, n = 5,515), stable mild hyperglycemia (SMH, n = 3,425), persistent hyperglycemia (PH, n = 2,080), and highly variable hyperglycemia (HVH, n = 157). Compared with NG, SMH, PH, and HVH were progressively associated with higher in-hospital mortality in the fully adjusted model, with HRs of 1.668 (95% CI: 1.469-1.894), 2.406 (95% CI: 2.083-2.779), and 5.766 (95% CI: 4.319-7.699), respectively. HVH remained associated with increased mortality in both diabetic and non-diabetic patients. Adding glucose trajectories to baseline prediction models modestly improved AUC, IDI, NRI, and predicted risk classification across LASSO, Boruta, and BSS-BIC models. In ICU patients with NTS, glucose trajectory phenotypes were associated with different risks of in-hospital mortality, with HVH showing the strongest association. Glucose trajectories may provide additional prognostic information for risk stratification beyond static glucose measurements.
Indexed as
Identifiers
42236965What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.